Market Cap 3.78B
Revenue (ttm) 802.80M
Net Income (ttm) 53.51M
EPS (ttm) N/A
PE Ratio 60.03
Forward PE 57.64
Profit Margin 6.67%
Debt to Equity Ratio 0.00
Volume 776,600
Avg Vol 590,390
Day's Range N/A - N/A
Shares Out 29.49M
Stochastic %K 9%
Beta 1.25
Analysts Strong Sell
Price Target $213.33

Company Profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerv...

Industry: Medical Devices
Sector: Healthcare
Phone: (844) 672-4357
Address:
5500 Wayzata Blvd., Suite 1600, Golden Valley, United States
JarvisFlow
JarvisFlow Jul. 15 at 1:09 PM
Morgan Stanley has updated their rating for Inspire Medical Systems ( $INSP ) to Overweight with a price target of 182.
0 · Reply
Upsidedownterry
Upsidedownterry Jul. 10 at 11:15 PM
$INSP $RMD $VVOS buy and hold onto your shares people. This is going to explode soon
1 · Reply
Estimize
Estimize Jul. 7 at 5:00 PM
Wall St is expecting 0.20 EPS for $INSP Q2 [Reporting 08/04 AMC] http://www.estimize.com/intro/insp?chart=historical&metric_name=eps&utm_co
0 · Reply
drknmstr01
drknmstr01 Jul. 7 at 2:17 PM
$INSP full position now
0 · Reply
GoldenTradesCapital
GoldenTradesCapital Jul. 4 at 11:04 AM
WATCHLIST – HEALTH TECH NAMES TO WATCH 🧬 • $OM – Precision surgeries • $EXAS – Cancer screening • $NVTA – Genomics • $INSP – Sleep apnea devices • $GH – Early detection diagnostics Follow us for sharper sector-focused watchlists 🔱
0 · Reply
Src947
Src947 Jul. 3 at 11:50 PM
$INSP facing an major increase in competition.
0 · Reply
Estimize
Estimize Jun. 30 at 11:00 AM
Wall St is expecting 0.20 EPS for $INSP Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/insp?chart=historical&metric_name=eps&utm_co
0 · Reply
MikiTrader
MikiTrader Jun. 10 at 12:56 PM
$IXHL asked AI what I was curious about. I felt a huge flow. It's also important to note that while non-orphan drugs that qualify as New Chemical Entities (NCEs) typically benefit from 5 years of data exclusivity under the Hatch-Waxman Act. Let me explain how I feel right now... I remember when Thor got hit by the Destroyer and rolled around on the ground, Loki was thrilled but Odin was crying. I don't know if IXHL can be compared to Thor, but won't this company find its original value? Personally, I think that $1, $2, $5, etc. are all gimmicks. NFA. $KLTO $DRUG $SLNO $AMAM $IMGN $REGN $NVAX $VKTX $PFE $LLY $RMD $INSP $PHG
0 · Reply
Pather
Pather Jun. 5 at 7:28 PM
$INSP filed a patent lawsuit against Nyxoah
1 · Reply
swingingtech
swingingtech Jun. 5 at 12:58 PM
$PRAA, $CRGY, $INSP https://wallstreetwaves.com/projected-19-growth-expected-for-rwj-holdings/
0 · Reply
Latest News on INSP
JarvisFlow
JarvisFlow Jul. 15 at 1:09 PM
Morgan Stanley has updated their rating for Inspire Medical Systems ( $INSP ) to Overweight with a price target of 182.
0 · Reply
Upsidedownterry
Upsidedownterry Jul. 10 at 11:15 PM
$INSP $RMD $VVOS buy and hold onto your shares people. This is going to explode soon
1 · Reply
Estimize
Estimize Jul. 7 at 5:00 PM
Wall St is expecting 0.20 EPS for $INSP Q2 [Reporting 08/04 AMC] http://www.estimize.com/intro/insp?chart=historical&metric_name=eps&utm_co
0 · Reply
drknmstr01
drknmstr01 Jul. 7 at 2:17 PM
$INSP full position now
0 · Reply
GoldenTradesCapital
GoldenTradesCapital Jul. 4 at 11:04 AM
WATCHLIST – HEALTH TECH NAMES TO WATCH 🧬 • $OM – Precision surgeries • $EXAS – Cancer screening • $NVTA – Genomics • $INSP – Sleep apnea devices • $GH – Early detection diagnostics Follow us for sharper sector-focused watchlists 🔱
0 · Reply
Src947
Src947 Jul. 3 at 11:50 PM
$INSP facing an major increase in competition.
0 · Reply
Estimize
Estimize Jun. 30 at 11:00 AM
Wall St is expecting 0.20 EPS for $INSP Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/insp?chart=historical&metric_name=eps&utm_co
0 · Reply
MikiTrader
MikiTrader Jun. 10 at 12:56 PM
$IXHL asked AI what I was curious about. I felt a huge flow. It's also important to note that while non-orphan drugs that qualify as New Chemical Entities (NCEs) typically benefit from 5 years of data exclusivity under the Hatch-Waxman Act. Let me explain how I feel right now... I remember when Thor got hit by the Destroyer and rolled around on the ground, Loki was thrilled but Odin was crying. I don't know if IXHL can be compared to Thor, but won't this company find its original value? Personally, I think that $1, $2, $5, etc. are all gimmicks. NFA. $KLTO $DRUG $SLNO $AMAM $IMGN $REGN $NVAX $VKTX $PFE $LLY $RMD $INSP $PHG
0 · Reply
Pather
Pather Jun. 5 at 7:28 PM
$INSP filed a patent lawsuit against Nyxoah
1 · Reply
swingingtech
swingingtech Jun. 5 at 12:58 PM
$PRAA, $CRGY, $INSP https://wallstreetwaves.com/projected-19-growth-expected-for-rwj-holdings/
0 · Reply
Estimize
Estimize Jun. 2 at 11:00 AM
Wall St is expecting 0.20 EPS for $INSP Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/insp?chart=historical&metric_name=eps&utm_co
0 · Reply
healthcareguru
healthcareguru May. 28 at 2:21 PM
$INSP this is likely to blowup on $NYXH approval imminently… Then you have GLP-1 on-label headwinds for the next year+ before annualizing. Not a good setup.
2 · Reply
Upsidedownterry
Upsidedownterry May. 21 at 9:01 PM
$VVOS the easy exit for Seneca is to facilitate selling Vivos to Resmed $RMD , CPAP giant valued at 36 Billion or inspire medical system $INSP, valued at 4.3 Billion. Stop worrying about Dollars and Pennies, wait for the 100s of millions reward. The new buying out sleep center model improve profit per patient from $4000 to $7000, and Seneca supports this move. Vivos treatment has the lowest life time cost for patient, a big incentive for insurance company to cover patient’s out of pocket cost. This is a business even an idiot can run profitably. Buy, wait, and be rewarded handsomely
1 · Reply
WarrantBuffet808
WarrantBuffet808 May. 18 at 6:44 PM
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce May. 13 at 3:52 PM
$INSP why don't inspire buy out vvos vivios , they are going to take them over one day anyway , they have a better product ,just buy them out while they are still so small.
0 · Reply
Richapeslayer_pounce
Richapeslayer_pounce May. 13 at 2:25 PM
$INSP VVOS is the next 50x look at the market cap and its already in the selling and growth stage right now about to post forst profitsble quarter.
0 · Reply
RobinFood46290
RobinFood46290 May. 13 at 12:59 PM
0 · Reply
drknmstr01
drknmstr01 May. 12 at 7:55 AM
$INSP time to get back in here, maybe this time not as a schwing 🍌
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 2:13 PM
JP Morgan has adjusted their stance on Inspire Medical Systems ( $INSP ), setting the rating to Overweight with a target price of 235 → 195.
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 1:00 PM
Baird has adjusted their stance on Inspire Medical Systems ( $INSP ), setting the rating to Outperform with a target price of 230 → 236.
0 · Reply
CaptainAmrica
CaptainAmrica May. 1 at 10:30 PM
$INSP. Sold for about break even...
0 · Reply
UrielEllison
UrielEllison Apr. 22 at 5:02 PM
$INSP time to move up 🚀 Breaking out — МаіnzВіоmеd now up +5.86% to $3.25 with volume approaching 100K. Momentum is real and building fast. Something’s brewing here... this move feels different. 👀 By Friday, a +100% move is still on the table — the technicals look strong and the sentiment across Reddit/Discord is electric. This one’s heating up quick. 🔥📈⁩
0 · Reply